Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Prot #B-VEC-03: A Phase III Efficacy and Safety Study of Beremagene Geperpavec (B-VEC, previously KB103) for the Treatment of Dystrophic Epidermolysis Bullosa (DEB)
Paller, Amy
(PD/PI)
Dermatology
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
12/22/20
→
12/22/23
Funding
Krystal Biotech, Inc.
((OE) Prot #B-VEC-03)
View all
View less